Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | ADAP | AADI | ||
| Company | Lineage Cell Therapeutics Inc | Adaptimmune Ther ADR | Aadi Biosciences Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 1.6000 | 1.7100 | 12.62 | ||
| High | 1.6400 | 1.7600 | 12.97 | ||
| Low | 1.5620 | 1.6300 | 12.31 | ||
| Last | 1.5800 | 1.6600 | 12.22 | ||
| Change | -0.0300 | -0.0500 | -0.76 | ||
| % Change | -1.86% | -2.92% | -5.86% | ||
| Volume | 594,150 | 212,494 | 77,457 | ||
| 20-Day Average Volume | 1,739,225 | 515,745 | 245,081 | ||
| Previous Close | 1.6100 | 1.7100 | 12.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4165 | 1.6428 | 13.72 | ||
| 20-Day Raw Stochastic | 92.86% | 64.29% | 12.16% | ||
| 20-Day Relative Strength | 61.18% | 51.98% | 43.42% | ||
| Weighted Alpha | -38.55 | -66.20 | -61.50 | ||
| Today's Opinion | 8% Buy | 48% Sell | 100% Sell | ||
| Previous Opinion | 8% Buy | 64% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.26% since 06/23/22 | -0.29% since 06/23/22 | -6.45% since 06/23/22 | ||
| Low | 1.2900 on 06/27/22 | 1.6050 on 06/24/22 | 11.72 on 06/28/22 | ||
| High | 1.6400 on 06/30/22 | 1.8499 on 06/28/22 | 13.50 on 06/24/22 | ||
| 1-Month | |||||
| %Chg | +22.90% since 05/27/22 | +14.14% since 05/27/22 | -19.41% since 05/27/22 | ||
| Low | 1.2200 on 06/16/22 | 1.4108 on 06/01/22 | 11.72 on 06/28/22 | ||
| High | 1.6400 on 06/30/22 | 1.9100 on 06/17/22 | 17.27 on 06/03/22 | ||
| 3-Month | |||||
| %Chg | +7.33% since 03/30/22 | -15.78% since 03/30/22 | -28.27% since 03/30/22 | ||
| Low | 1.1000 on 05/16/22 | 1.2600 on 05/12/22 | 11.00 on 05/12/22 | ||
| High | 1.6400 on 06/30/22 | 2.3400 on 04/08/22 | 18.47 on 04/05/22 | ||
| 6-Month | |||||
| %Chg | -35.60% since 12/30/21 | -55.17% since 12/30/21 | -50.16% since 12/30/21 | ||
| Low | 1.1000 on 05/16/22 | 1.2600 on 05/12/22 | 11.00 on 05/12/22 | ||
| High | 2.5750 on 01/03/22 | 4.1200 on 01/04/22 | 25.35 on 01/12/22 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 273,261 | 277,053 | 271,827 | ||
| Shares Outstanding, K | 169,727 | 162,019 | 20,942 | ||
| Annual Sales | 4,340,000 | 6,150,000 | 1,120,000 | ||
| Annual Net Income | -43,020,000 | -158,090,000 | -110,090,000 | ||
| Last Quarter Sales | 5,240,000 | 3,580,000 | 2,310,000 | ||
| Last Quarter Net Income | -7,090,000 | -50,270,000 | -13,860,000 | ||
| 60-Month Beta | 1.89 | 2.08 | 1.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 05/12/22 | -0.32 on 05/09/22 | -0.66 on 05/12/22 | ||
| Latest Earnings Date | 08/11/22 | 08/08/22 | 08/10/22 | ||
| Most Recent Dividend | 0.080 on 12/15/03 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
